Medicare Enrolled

Dr. Chad Amosson, MD

Radiology - Diagnostic · Plano, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6957 W PLANO PKWY STE 1300, Plano, TX 75093
9728201400
In practice since 2005 (20 years)
NPI: 1790786879 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amosson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amosson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amosson

Dr. Chad Amosson is a radiology - diagnostic in Plano, TX, with 20 years in practice. Based on federal Medicare data, Dr. Amosson performed 4,004 Medicare services across 729 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amosson received a total of $3,395 from 40 pharmaceutical and/or device companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiology - diagnostic. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amosson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 25% volume in TX$ $3,395 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,004
Medicare services
Top 25% in TX for radiology - diagnostic
729
Unique beneficiaries
$235
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~200 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Contrast dye for imaging (iodine-based)1,452$0$0
Piflufolastat f-18, diagnostic, 1 millicurie755$494$1,441
CT guidance for radiation therapy496$92$276
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session470$272$806
Nuclear medicine study from skull base to mid-thigh with ct scan209$1,141$7,086
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries158$101$582
Continuing radiation therapy consultation per week97$65$200
Radiation treatment management, 5 treatment sessions95$147$444
Calculation of radiation therapy dose61$50$163
Nuclear medicine study whole body with ct scan53$1,129$3,190
New patient office visit (45-59 min)34$124$384
Complex radiation therapy planning33$130$397
High precision radiation therapy planning27$1,357$4,378
Design and construction of radiation treatment device for high precision radiation therapy27$354$1,097
Ct scan of chest with contrast21$63$458
CT scan of abdomen and pelvis with contrast16$192$846
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,395
Total received (2018-2024)
Avg $679/year across 5 years
Top 21% in TX for radiology - diagnostic
40
Companies
192
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,395 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$101
2023
$316
2022
$147
2019
$650
2018
$2,181

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$502
E.R. Squibb & Sons, L.L.C.
$201
Amgen Inc.
$171
AstraZeneca Pharmaceuticals LP
$163
GENZYME CORPORATION
$162
icotec Medical Inc.
$147
Lilly USA, LLC
$146
Progenics Pharmaceuticals, Inc.
$140
Pharmacyclics LLC, An AbbVie Company
$135
TESARO, Inc.
$135
Janssen Biotech, Inc.
$121
Integra LifeSciences Corporation
$111
Genentech USA, Inc.
$106
Astellas Pharma US Inc
$92
Blue Earth Diagnostics Limited
$91
Takeda Pharmaceuticals U.S.A., Inc.
$86
Incyte Corporation
$84
Sirtex Medical Inc
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
EMD Serono, Inc.
$67
Agios Pharmaceuticals, Inc.
$64
Seattle Genetics, Inc.
$63
Bayer HealthCare Pharmaceuticals Inc.
$59
Celgene Corporation
$54
Exelixis Inc.
$43
AbbVie, Inc.
$33
Clovis Oncology, Inc.
$31
MEDTEC LLC
$28
Sumitomo Pharma America, Inc.
$24
Edwards Lifesciences Corporation
$24
Rigel Pharmaceuticals, Inc.
$24
Telix Pharmaceuticals
$21
Boston Scientific Corporation
$16
TerSera Therapeutics LLC
$16
BTG International, Inc.
$15
INSYS Therapeutics Inc
$15
Janssen Scientific Affairs, LLC
$14
Novocure Inc.
$13
PFIZER INC.
$13
Augmenix, Inc.
$12
Top 3 companies account for 25.7% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Abraxane · Aranesp · Avastin · Axumin · Bavencio · CALQUENCE · CODMAN CERTAS · CYRAMZA · Cabometyx · DARZALEX · EMPLICITI · ERBITUX · Erleada · FloTrac Sensor · GILOTRIF · Herceptin · IBRANCE · ILLUCCIX · IMFINZI · Idhifa · Imbruvica · JADENU · JAKAFI · JEVTANA · KISQALI · Kyprolis · LIBTAYO · MEKINIST · NINLARO · Nexavar · Nplate · OPDIVO · ORGOVYX · Oncology · POSLUMA · PYLARIFY · Perjeta · RYDAPT · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SIR-Spheres Microspheres · SPRYCEL · SYNDROS · SpaceOAR · SpaceOAR VUE System - 10mL · Stivarga · TASIGNA · TAXOTERE · TIBSOVO · Tavalisse · VERZENIO · VORAXAZE · VOTRIENT · Venclexta · Vitrakvi · XOSPATA · XTANDI · ZEJULA · ZOLADEX · ZYTIGA · icotec Medical BlackArmor Spine Oncology System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $85 per 100 Medicare services performed
Looking for a radiology - diagnostic in Plano?
Compare radiology - diagnostics in the Plano area by procedure volume, costs, and industry payment transparency.
Browse radiology - diagnostics nearby

Geographic Context

Radiology - Diagnostics within 10 mi
55
Per 100K population
4.9
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Amosson is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Amosson experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Amosson performed 1,452 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amosson receive payments from pharmaceutical companies?
Yes. Dr. Amosson received a total of $3,395 from 40 companies across 192 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amosson's costs compare to other radiology - diagnostics in Plano?
Dr. Amosson's average Medicare payment per service is $235. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amosson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →